Proxalutamide for the treatment of COVID-19 rebound following Paxlovid treatment: Report of four cases and review of the literature.

Da-Wei YangMin-Jie JuHao WangYi-Chen JiaXiao-Dan WangHao FangJia Fan

Published in: Journal of clinical laboratory analysis (2023)

Our cases suggested that proxalutamide might be an effective remedial treatment option for patients experiencing a COVID-19 rebound after Paxlovid treatment.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
chronic kidney disease
ejection fraction
peritoneal dialysis